Search

Your search keyword '"Bourguignon, Thierry"' showing total 15 results
Start Over Author "Bourguignon, Thierry" Publication Year Range Last 3 years
15 results on '"Bourguignon, Thierry"'

1. Right Ventriculoarterial Coupling Surrogates and Long-Term Survival in LVAD Recipients: Results of the ASSIST-ICD Multicentric Registry

Author

BENEYTO, MAXIME, MARTINS, RAPHAËL, GALAND, VINCENT, KINDO, MICHEL, SCHNEIDER, CLÉMENT, SEBESTYEN, ALEXANDRE, BOIGNARD, AUDE, SEBBAG, LAURENT, POZZI, MATTEO, GENET, THIBAUD, BOURGUIGNON, THIERRY, MARTIN, ANNE-CÉLINE, ACHOUH, PAUL, VANHUYSE, FABRICE, BLANG, HUGUES, DAVID, CHARLES HENRI, MICHEL, MAGALI, ANSELME, FRÉDÉRIC, LITZLER, PIERRE-YVES, JUNGLING, MARIE, VINCENTELLI, ANDRÉ, ESCHALIER, ROMAIN, D'OSTREVY, NICOLAS, NATAF, PATRICK, PARA, MARYLOU, GARNIER, FABIEN, RAJINTHAN, PRIYANKA, PORTERIE, JEAN, FAURE, MAXIME, PICARD, FRANÇOIS, GAUDARD, PHILIPPE, ROUVIÈRE, PHILIPPE, BABATASI, GÉRARD, BLANCHART, KATRIEN, GARIBOLDI, VLAD, PORTO, ALIZÉE, FLECHER, ERWAN, and DELMAS, CLEMENT

Published
2024
Full Text
View/download PDF

7. Durability of bioprosthetic aortic valve replacement in patients under the age of 60 years – 1-year follow-up from the prospective INDURE registry

Author

Meuris, Bart, primary, Roussel, Jean-Christian, additional, Borger, Michael A, additional, Siepe, Matthias, additional, Stefano, Pierluigi, additional, Laufer, Günther, additional, Langanay, Thierry, additional, Theron, Alexis, additional, Grabenwöger, Martin, additional, Binder, Konrad, additional, Demers, Philippe, additional, Pessotto, Renzo, additional, van Leeuwen, Wouter, additional, Bourguignon, Thierry, additional, Canovas, Sergio, additional, Mariscalco, Giovanni, additional, Coscioni, Enrico, additional, Dagenais, Francois, additional, Wendler, Olaf, additional, Polvani, Gianluca, additional, Eden, Matthias, additional, Botta, Beate, additional, Bramlage, Peter, additional, and De Paulis, Ruggero, additional

Published
2023
Full Text
View/download PDF

9. Durability of bioprosthetic aortic valve replacement in patients under the age of 60 years - 1-year follow-up from the prospective INDURE registry

Author

Meuris, Bart, Roussel, Jean-Christian, Borger, Michael A, Siepe, Matthias, Stefano, Pierluigi, Laufer, Günther, Langanay, Thierry, Theron, Alexis, Grabenwöger, Martin, Binder, Konrad, Demers, Philippe, Pessotto, Renzo, van Leeuwen, Wouter, Bourguignon, Thierry, Canovas, Sergio, Mariscalco, Giovanni, Coscioni, Enrico, Dagenais, Francois, Wendler, Olaf, Polvani, Gianluca, Eden, Matthias, Botta, Beate, Bramlage, Peter, and De Paulis, Ruggero

Subjects
610 Medicine & health
Abstract

OBJECTIVES We report 1-year safety and clinical outcomes in patients

Published
2023
Full Text
View/download PDF

10. Predictors of Device-Related Thrombus Following Percutaneous Left Atrial Appendage Occlusion

Author

Fauchier, Grégoire, Bisson, Arnaud, Bodin, Alexandre, Herbert, Julien, Semaan, Carl, Angoulvant, Denis, Ducluzeau, Pierre Henri, Lip, Gregory, Fauchier, Laurent, Deharo, Pierre, Cuisset, Thomas, Lacour, Thibaud, Etienne, Christophe Saint, Jaussaud, Nicolas, Morera, Pierre, Spychaj, Jean-Charles, Porto, Alizée, Collart, Frederic, Theron, Alexis, Bernard, Anne, Bourguignon, Thierry, Simard, Trevor, Jung, Richard, Lehenbauer, Kyle, Piayda, Kerstin, Pracoń, Radoslaw, Jackson, Gregory, Flores-Umanzor, Eduardo, Faroux, Laurent, Korsholm, Kasper, Chun, Julian K.R., Chen, Shaojie, Maarse, Moniek, Montrella, Kristi, Chaker, Zakeih, Spoon, Jocelyn, Pastormerlo, Luigi, Meincke, Felix, Sawant, Abhishek, Moldovan, Carmen, Qintar, Mohammed, Aktas, Mehmet, Branca, Luca, Radinovic, Andrea, Ram, Pradhum, El-Zein, Rayan, Flautt, Thomas, Ding, Wern Yew, Sayegh, Bassel, Benito-González, Tomás, Lee, Oh-Hyun, Badejoko, Solomon, Paitazoglou, Christina, Karim, Nabeela, Zaghloul, Ahmed, Agrawal, Himanshu, Kaplan, Rachel, Alli, Oluseun, Ahmed, Aamir, Suradi, Hussam, Knight, Bradley, Alla, Venkata, Panaich, Sidakpal, Wong, Tom, Bergmann, Martin, Chothia, Rashaad, Kim, Jung-Sun, Pérez de Prado, Armando, Bazaz, Raveen, Gupta, Dhiraj, Valderrabano, Miguel, Sanchez, Carlos, El Chami, Mikhael, Mazzone, Patrizio, Adamo, Marianna, Ling, Fred, Wang, Dee Dee, O’neill, William, Wojakowski, Wojtek, Pershad, Ashish, Berti, Sergio, Spoon, Daniel, Kawsara, Akram, Jabbour, George, Boersma, Lucas V.A., Schmidt, Boris, Nielsen-Kudsk, Jens Erik, Rodés-Cabau, Josep, Freixa, Xavier, Ellis, Christopher, Demkow, Marcin, Sievert, Horst, Main, Michael, Hibbert, Benjamin, Holmes, David, Alkhouli, Mohamad, Centre Hospitalier Régional Universitaire de Tours (CHRU Tours), CHU Trousseau [Tours], Éducation Éthique Santé EA 7505 (EES), Université de Tours (UT), EA4245 - Transplantation, Immunologie, Inflammation [Tours] (T2i), University of Liverpool, Aalborg University [Denmark] (AAU), Centre recherche en CardioVasculaire et Nutrition = Center for CardioVascular and Nutrition research (C2VN), Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), Hôpital de la Timone [CHU - APHM] (TIMONE), Nutrition, obésité et risque thrombotique (NORT), Institut National de la Recherche Agronomique (INRA)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Marseille, Département de Cardiologie [Hôpital de la Timone - APHM], Assistance Publique - Hôpitaux de Marseille (APHM)- Hôpital de la Timone [CHU - APHM] (TIMONE), Institut de neurophysiopathologie (INP), Aix Marseille Université (AMU)-Centre National de la Recherche Scientifique (CNRS), University of Ottawa [Ottawa], Université Laval [Québec] (ULaval), National Institute for Research and Development in Microtechnologies (IMT-Bucharest), Graduate School, Cardiology, and ACS - Heart failure & arrhythmias

Subjects
Male, Cardiac Catheterization, Time Factors, Percutaneous, left atrial appendage occlusion, Septal Occluder Device, medicine.medical_treatment, Transesophageal, [SHS]Humanities and Social Sciences, Pulmonary vein, Postoperative Complications, Risk Factors, Interquartile range, Atrial Fibrillation, Registries, Embolization, ComputingMilieux_MISCELLANEOUS, Watchman, Incidence, Atrial fibrillation, Europe, Survival Rate, Treatment Outcome, Echocardiography, Cardiology, Female, Watchman FLX, Cardiology and Cardiovascular Medicine, medicine.medical_specialty, Heart Diseases, ACP, Amplatzer cardiac plug, Amulet, DRT, LAAO, device-related thrombus, Aged, Atrial Appendage, Echocardiography, Transesophageal, Follow-Up Studies, Humans, Thrombosis, Left atrial appendage occlusion, Internal medicine, medicine, Risk factor, Thrombus, business.industry, medicine.disease, business
Abstract

Background: Device-related thrombus (DRT) has been considered an Achilles’ heel of left atrial appendage occlusion (LAAO). However, data on DRT prediction remain limited. Objectives: This study constructed a DRT registry via a multicenter collaboration aimed to assess outcomes and predictors of DRT. Methods: Thirty-seven international centers contributed LAAO cases with and without DRT (device-matched and temporally related to the DRT cases). This study described the management patterns and mid-term outcomes of DRT and assessed patient and procedural predictors of DRT. Results: A total of 711 patients (237 with and 474 without DRT) were included. Follow-up duration was similar in the DRT and no-DRT groups, median 1.8 years (interquartile range: 0.9-3.0 years) versus 1.6 years (interquartile range: 1.0-2.9 years), respectively (P = 0.76). DRTs were detected between days 0 to 45, 45 to 180, 180 to 365, and >365 in 24.9%, 38.8%, 16.0%, and 20.3% of patients. DRT presence was associated with a higher risk of the composite endpoint of death, ischemic stroke, or systemic embolization (HR: 2.37; 95% CI, 1.58-3.56; P < 0.001) driven by ischemic stroke (HR: 3.49; 95% CI: 1.35-9.00; P = 0.01). At last known follow-up, 25.3% of patients had DRT. Discharge medications after LAAO did not have an impact on DRT. Multivariable analysis identified 5 DRT risk factors: hypercoagulability disorder (odds ratio [OR]: 17.50; 95% CI: 3.39-90.45), pericardial effusion (OR: 13.45; 95% CI: 1.46-123.52), renal insufficiency (OR: 4.02; 95% CI: 1.22-13.25), implantation depth >10 mm from the pulmonary vein limbus (OR: 2.41; 95% CI: 1.57-3.69), and non-paroxysmal atrial fibrillation (OR: 1.90; 95% CI: 1.22-2.97). Following conversion to risk factor points, patients with ≥2 risk points for DRT had a 2.1-fold increased risk of DRT compared with those without any risk factors. Conclusions: DRT after LAAO is associated with ischemic events. Patient- and procedure-specific factors are associated with the risk of DRT and may aid in risk stratification of patients referred for LAAO.

Published
2021

11. A Simplified Delivery Frozen Elephant Trunk Technique to Reduce Circulatory Arrest Time in Hybrid Aortic Arch Surgery: Early Results in a Cohort of 158 Patients

Author

Guimbretiere, Guillaume, additional, Bonnet, Nicolas, additional, Gonthier, Sebastien, additional, Crepon, Clementine, additional, Fouquet, Olivier, additional, Kermen, Stephane, additional, Bourguignon, Thierry, additional, Tomasi, Jacques, additional, Braunberger, Eric, additional, and Senage, Thomas, additional

Published
2022
Full Text
View/download PDF

14. Outcome of Temporary Circulatory Support As a Bridge-to-Left Ventricular Assist Device Strategy in Cardiogenic Shock Patients

Author

Bidaut, Auriane, primary, Flécher, Erwan, additional, Nesseler, Nicolas, additional, Bounader, Karl, additional, Vincentelli, André, additional, Moussa, Mouhammed, additional, Delmas, Clément, additional, Porterie, Jean, additional, Nubret, Karine, additional, Pernot, Mathieu, additional, Kindo, Michel, additional, Schneider, Clément, additional, Gaudard, Philippe, additional, Rouvière, Philippe, additional, Michel, Magali, additional, Sénage, Thomas, additional, Boignard, Aude, additional, Chavanon, Olivier, additional, Verdonk, Constance, additional, Para, Marylou, additional, Maille, Baptiste, additional, Gariboldi, Vlad, additional, Pozzi, Matteo, additional, Hugon-Vallet, Elisabeth, additional, Litzler, Pierre-Yves, additional, Anselme, Frédéric, additional, Blanchart, Katrien, additional, Babatasi, Gerard, additional, Bielefeld, Marie, additional, Grosjean, Sandrine, additional, Radu, Costin, additional, Hamon, David, additional, Bourguignon, Thierry, additional, Genet, Thibaud, additional, Eschalier, Romain, additional, D’Ostrevy, Nicolas, additional, Nougue, Hélène, additional, Martin, Anne Cécile, additional, Vanhuyse, Fabrice, additional, Blangy, Hugues, additional, Leclercq, Christophe, additional, Martins, Raphael P., additional, and Galand, Vincent, additional

Published
2022
Full Text
View/download PDF

15. Association between pulmonary artery pulsatility and mortality after implantation of left ventricular assist device.

Author

Akamkam A, Galand V, Jungling M, Delmas C, Dambrin C, Pernot M, Kindo M, Gaudard P, Rouviere P, Senage T, Chavanon O, Para M, Gariboldi V, Pozzi M, Litzler PY, Babatasi G, Bouchot O, Radu C, Bourguignon T, D'Ostrevy N, Abi Akar R, Vanhuyse F, Gaillard M, Chatelier G, Fels A, Flecher E, and Guihaire J

Abstract

Aims: Right ventricular failure after left ventricular assist device (LVAD) implantation is a major concern that remains challenging to predict. We sought to investigate the relationship between preoperative pulmonary artery pulsatility index (PAPi) and mortality after LVAD implantation., Methods and Results: A retrospective analysis of the ASSIST-ICD multicentre registry allowed the assessment of PAPi before LVAD according to the formula [(systolic pulmonary artery pressure - diastolic pulmonary artery pressure)/central venous pressure]. The primary endpoint was survival at 3 months, according to the threshold value of PAPi determined by the receiver operating characteristic (ROC) curve. A multivariate analysis including demographic, echographic, haemodynamic, and biological variables was performed to identify predictive factors for 2 year mortality. One hundred seventeen patients were included from 2007 to 2021. The mean age was 58.45 years (±13.16), with 15.4% of women (sex ratio 5.5). A total of 53.4% were implanted as bridge to transplant and 43.1% as destination therapy. Post-operative right ventricular failure was observed in 57 patients (48.7%), with no significant difference between survivors and non-survivors at 1 month (odds ratio 1.59, P = 0.30). The median PAPi for the whole study population was 2.83 [interquartile range 1.63-4.69]. The threshold value of PAPi determined by the ROC curve was 2.84. Patients with PAPi ≥ 2.84 had a higher survival rate at 3 months [PAPi < 2.84: 58.1% [46.3-72.8%] vs. PAPi ≥ 2.84: 89.1% [81.1-97.7%], hazard ratio (HR) 0.08 [0.02-0.28], P < 0.01], with no significant difference after 3 months (HR 0.67 [0.17-2.67], P = 0.57). Other predictors of 2 year mortality were systemic hypertension (HR 4.22 [1.49-11.97], P < 0.01) and diabetes mellitus (HR 4.90 [1.83-13.14], P < 0.01). LVAD implantation as bridge to transplant (HR 0.18 [0.04-0.74], P = 0.02) and heart transplantation (HR 0.02 [0.00-0.18], P < 0.01) were associated with a higher survival rate at 2 years., Conclusions: Preoperative PAPi < 2.84 was associated with a higher risk of early mortality after LVAD implantation without impacting 2 year outcomes among survivors., (© 2024 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.)

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results